{
    "eid": "2-s2.0-85082708676",
    "title": "Fatty acid\u2013binding protein 4 downregulation drives calcification in the development of kidney stone disease",
    "cover-date": "2020-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "fatty acid\u2013binding protein",
        "kidney stone",
        "metabolic syndrome",
        "Randall's plaque",
        "RNA-sequence"
    ],
    "authors": [
        "Kazumi Taguchi",
        "Ling Chen",
        "Manint Usawachintachit",
        "Shuzo Hamamoto",
        "Misun Kang",
        "Teruaki Sugino",
        "Rei Unno",
        "David T. Tzou",
        "Benjamin A. Sherer",
        "Atsushi Okada",
        "Takahiro Yasui",
        "Sunita P. Ho",
        "Marshall L. Stoller",
        "Thomas Chi"
    ],
    "citedby-count": 11,
    "ref-count": 52,
    "ref-list": [
        "Epidemiology of stone disease across the world",
        "Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030",
        "New insights regarding the interrelationship of obesity, diet, physical activity, and kidney stones",
        "Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan",
        "Do stones still kill? An analysis of death from stone disease 1999-2013 in England and Wales",
        "Idiopathic hypercalciuria and formation of calcium renal stones",
        "Genome-wide gene expression profiling of Randall's plaques in calcium oxalate stone formers",
        "The origins of urinary stone disease: upstream mineral formations initiate downstream Randall's plaque",
        "RNA-Seq: a revolutionary tool for transcriptomics",
        "Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells",
        "Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis",
        "Next-generation sequencing of transcriptomes: a guide to RNA isolation in nonmodel animals",
        "Association of Randall plaque with collagen fibers and membrane vesicles",
        "Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection",
        "Genome-wide analysis of denes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity",
        "Genetic risk factors for idiopathic urolithiasis: a systematic review of the literature and causal network analysis",
        "Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets",
        "Obesity, weight gain, and the risk of kidney stones",
        "Body mass index and kidney stones: a cohort study of Japanese men",
        "Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence",
        "Visceral fat accumulation is a risk factor for urinary stone",
        "A paracrine mechanism involving renal tubular cells, adipocytes and macrophages promotes kidney stone formation in a simulated metabolic syndrome environment",
        "Increased crystal\u2013cell interaction in vitro under co-culture of renal tubular cells and adipocytes by in vitro co-culture paracrine systems simulating metabolic syndrome",
        "Insulin resistance increases the risk of urinary stone formation in a rat model of metabolic syndrome",
        "Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome",
        "Effect of Adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis",
        "Structural and functional analysis of fatty acid-binding proteins",
        "Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases",
        "Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells",
        "Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction",
        "Common genetic variants in fatty acid\u2013binding protein-4 (FABP4) and clinical diabetes risk in the Women's Health Initiative Observational Study",
        "Common FABP4 genetic variants and plasma levels of fatty acid binding protein 4 in older adults",
        "Pioglitazone, a peroxisome proliferator activated receptor \u03b3 agonist, decreases renal crystal deposition, oxidative stress and inflammation in hyperoxaluric rats",
        "Differential roles of peroxisome proliferator-activated receptor-\u03b1 and receptor-\u03b3 on renal crystal formation in hyperoxaluric rodents",
        "Longitudinal transcriptome analysis reveals a sustained differential gene expression signature in patients treated for acute lyme disease",
        "M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development",
        "Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria",
        "Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients",
        "Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD)",
        "Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein",
        "Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction",
        "Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria",
        "Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease",
        "Pathophysiology-based treatment of urolithiasis",
        "Proinflammatory and metabolic changes facilitate renal crystal deposition in an obese mouse model of metabolic syndrome",
        "Optimizing RNA extraction of renal papilla biopsy tissue in kidney stone formers: a new methodology for genomic study",
        "Rationale and design of the registry for stones of the kidney and ureter (ReSKU): a prospective observational registry to study the natural history of urolithiasis patients",
        "Orchestrating high-throughput genomic analysis with Bioconductor",
        "Novel insights into renal mineralization and stone formation through advanced imaging modalities",
        "Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein",
        "Colony-stimulating factor-1 signaling suppresses renal crystal formation",
        "Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics"
    ],
    "affiliation": [
        {
            "affiliation-city": "San Francisco",
            "@id": "60023691",
            "affilname": "University of California, San Francisco",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nagoya",
            "@id": "60004321",
            "affilname": "Nagoya City University Graduate School of Medical Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004321",
            "affiliation-country": "Japan"
        }
    ],
    "funding": [
        "US National Institutes of Health",
        "University of California",
        "Naito Foundation",
        "UCSF",
        "Boston Scientific Corporation",
        "JSPS",
        "Mochida Memorial Foundation for Medical and Pharmaceutical Research"
    ]
}